权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies

癌症相关成纤维细胞改变实体恶性肿瘤中 B 细胞的组成

基本信息

批准号：
10213442
负责人：
SANDRA ORSULIC
金额：
$ 35.69万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-08-01 至 2022-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10213442
关键词：
Address Affect Antineoplastic Agents Area Attention Autoimmune Diseases B cell differentiation B cell therapy B-Cell Development B-Cell Neoplasm B-Lymphocyte Subsets B-Lymphocytes Bone Marrow Cell Maturation Cells Clinical Coculture Techniques Colon Carcinoma Color Complement Factor B Development Equilibrium Fibroblasts Flow Cytometry Foundations Gene Expression Profile Genes Genetically Engineered Mouse Hematologic Neoplasms Hematopoietic Homeostasis Homing Immune Immune system Immunohistochemistry Immunotherapy Impairment In Vitro Individual Lymphoid Malignant Neoplasms Malignant neoplasm of ovary Maps Mature B-Lymphocyte Memory B-Lymphocyte Modeling Mus Neoplasm Metastasis Outcome Ovarian Participant Patients Plasma Cells Play Primary Neoplasm Production Research Role Signal Transduction Solid Solid Neoplasm Source Stromal Cells Structure Structure of germinal center of lymph node System T-Lymphocyte Testing Transforming Growth Factors Tumor Immunity Tumor Promotion Wild Type Mouse cancer biomarkers cancer therapy cancer type cytokine experimental study genetic signature immune activation immunogenicity immunoregulation improved in silico in vivo interest large cell Diffuse non-Hodgkin&apos s lymphoma lymph nodes lymphoid organ lymphoid structures malignant breast neoplasm metastatic colorectal novel strategies outcome forecast ovarian neoplasm patient subsets recruit success therapeutic target tumor tumor growth tumor microenvironment tumor progression tumor xenograft tumorigenic

项目摘要

Tumor stroma is increasingly recognized as an active participant in tumor progression. The two most prominent stromal components in solid malignancies are immune cells and cancer-associated fibroblasts (CAFs). Typically, the presence of immune cells is associated with favorable survival while the presence of CAFs is associated with unfavorable survival. Although B-cell infiltrates are common in solid malignancies, their contribution to survival has not been studied in detail. Both pro- and anti-tumor functions have been demonstrated depending on the experimental system and markers used to detect B cells. The possibility that B cells in different stages of differentiation have opposite effects on tumor progression has not been tested as most prior studies used B-cell markers that detect a broad range of B-cell subsets. If certain subsets of B cells are associated with tumor progression, we hypothesize that they will be enriched in metastases when compared to primary tumors. Metastases typically have a higher content of CAFs than primary tumors. The interdependence between B cells and CAFs has not been studied; however, it has recently been shown that lymphoid organizer fibroblasts (LOFs) in normal lymph nodes regulate B cell recruitment to germinal centers (GCs). We found that CAFs and LOFs share a common gene expression profile. This led us to hypothesize that CAFs in solid tumors assume the function of LOFs to recruit and arrest B cells in the GC-stage of development, thereby diminishing the production of functionally mature B cells. The proposed study will characterize and quantitate the composition of B cells in matched primary and metastatic ovarian tumors using combinations of markers that identify distinct stages of B-cell differentiation. The functional interdependence between B cells and CAFs will be studied in co-cultures by quantitating the ability of CAFs to affect B-cell recruitment, survival, and differentiation as well as the ability of B cells to potentiate pro-tumorigenic features of CAFs. The interdependence between B cells and CAFs and its effect on tumor progression will be tested in several genetically engineered mouse tumor models in which either subsets of B cells or CAFs are inactivated. In addition to exploring a research area that has received limited attention in the past, the proposed study addresses an urgent need for more effective immunotherapies. The success of B-cell therapies in hematologic malignancies and autoimmune diseases and the emergence of new B-cell-directed agents have re-ignited interest in B cells as therapeutic targets in solid tumors. However, a more detailed understanding of different B- cell subsets and their roles in tumor growth are required for selective depletion of the tumor-promoting B-cell subsets and/or control of their equilibrium in solid tumors. Our study will yield a quantitative map of individual subsets of B-cells in matched primary tumors and metastases, clarify the potential role of CAFs in derailing B- cell maturation and test whether inactivation of CAF function could be used as a novel approach to improve tumor immunogenicity.

肿瘤间质越来越被认为是肿瘤进展的积极参与者。两个最实体恶性肿瘤中的主要基质成分是免疫细胞和癌症相关的成纤维细胞（CAFs）。通常，免疫细胞的存在与有利的存活相关，而免疫细胞的存在与有利的存活相关。 CAF与不利的生存有关。虽然B细胞浸润在实体恶性肿瘤中很常见，它们对生存的贡献尚未得到详细研究。促肿瘤和抗肿瘤功能均已被证实。这取决于用于检测B细胞的实验系统和标志物。B 尚未测试不同分化阶段的细胞对肿瘤进展具有相反的影响，大多数先前的研究使用检测宽范围B细胞亚群的B细胞标记。如果某些B细胞亚群与肿瘤进展相关，我们假设当肿瘤转移时，与原发性肿瘤相比。转移瘤通常具有比原发性肿瘤更高的CAF含量。的 B细胞和CAF之间的相互依赖性尚未研究;然而，最近显示，正常淋巴结中的淋巴样组织成纤维细胞（LOF）调节B细胞向生发中心的募集（GC）。我们发现CAFs和LOFs具有共同的基因表达谱。这让我们假设实体瘤中的CAF承担LOF的功能，以募集和阻滞GC期的B细胞，发育，从而减少功能成熟B细胞的产生。拟定的研究将使用免疫组织化学方法表征和定量匹配的原发性和转移性卵巢肿瘤中B细胞的组成， - 识别B细胞分化的不同阶段的标志物的组合。功能上的相互依赖将通过定量CAF影响B细胞的能力来研究共培养物中B细胞和CAF之间的相互作用募集、存活和分化以及B细胞增强肿瘤细胞的促肿瘤发生特征的能力。咖啡馆。B细胞和CAF之间的相互依赖性及其对肿瘤进展的影响将在几种基因工程小鼠肿瘤模型，其中B细胞或CAF的亚群被灭活。除了探索一个过去受到有限关注的研究领域外，解决了对更有效的免疫疗法的迫切需求。B细胞疗法在血液病中的成功恶性肿瘤和自身免疫性疾病以及新的B细胞导向剂的出现重新点燃了关注B细胞作为实体瘤治疗靶点。然而，更详细地了解不同的B- 细胞亚群及其在肿瘤生长中的作用是选择性消耗促肿瘤B细胞所必需的亚群和/或控制它们在实体瘤中的平衡。我们的研究将产生一个定量地图的个人匹配的原发肿瘤和转移瘤中B细胞亚群，阐明CAF在使B- 细胞成熟，并测试CAF功能的失活是否可以作为一种新的方法来改善肿瘤免疫原性

项目成果

期刊论文数量（8）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?

DOI：
10.3389/fcell.2020.00647
发表时间：
2020-07-17
期刊：
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
影响因子：
5.5
作者：
Hu, Ye;Taylor-Harding, Barbie;Orsulic, Sandra
通讯作者：
Orsulic, Sandra

DOI：
10.1016/j.canlet.2016.09.001
发表时间：
2016-11-28
期刊：
CANCER LETTERS
影响因子：
9.7
作者：
Jia, Dongyu;Liu, Zhenqiu;Deng, Nan;Tan, Tuan Zea;Huang, Ruby Yun-Ju;Taylor-Harding, Barbie;Cheon, Dong-Joo;Lawrenson, Kate;Wiedemeyer, Wolf R.;Walts, Ann E.;Karlan, Beth Y.;Orsulic, Sandra
通讯作者：
Orsulic, Sandra

Inflammation is a key contributor to ovarian cancer cell seeding.